Global Dental Burs Market 2024
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
Vaccination is a simple, safe, and effective way of protecting people against harmful diseases before they come into contact with them. Garnering a CAGR of 6.7% from 2021 to 2027, the global vaccine market is projected to reach worth of USD 51,149 million by 2027-end, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global vaccine market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the vaccine industry.
The vaccine market is segmented on the basis of vaccine type, indication, end user, and region. The vaccine market is segmented as below:
By vaccine type:
– recombinant & conjugate vaccines
– live attenuated vaccines
– inactivated vaccines
– toxoid vaccines
– others
By indication:
– diphtheria, pertussis, & tetanus (DTP)
– human papillomavirus (HPV)
– influenza
– measles, mumps, & rubella (MMR)
– meningococcal disease
– pneumococcal disease
– rotavirus
– others
By end user:
– pediatric
– adults
By region:
– region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The report also provides a detailed analysis of several leading vaccine market vendors that include Abbott Laboratories, AstraZeneca plc, Bavarian Nordic A/S, Emergent BioSolutions Inc., GlaxoSmithKline plc, Johnson & Johnson (J&J), Merck & Co., Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global vaccine market.
– To classify and forecast the global vaccine market based on vaccine type, indication, end user, and region.
– To identify drivers and challenges for the global vaccine market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global vaccine market.
– To identify and analyze the profile of leading players operating in the global vaccine market.
Why Choose This Report
– Gain a reliable outlook of the global vaccine market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary
Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints
Part 5. Global market for vaccine by vaccine type
5.1 Recombinant & conjugate vaccines
5.1.1 Market size and forecast
5.2 Live attenuated vaccines
5.2.1 Market size and forecast
5.3 Inactivated vaccines
5.3.1 Market size and forecast
5.4 Toxoid vaccines
5.4.1 Market size and forecast
5.5 Others
5.5.1 Market size and forecast
Part 6. Global market for vaccine by indication
6.1 Diphtheria, pertussis, & tetanus (DTP)
6.1.1 Market size and forecast
6.2 Human papillomavirus (HPV)
6.2.1 Market size and forecast
6.3 Influenza
6.3.1 Market size and forecast
6.4 Measles, mumps, & rubella (MMR)
6.4.1 Market size and forecast
6.5 Meningococcal disease
6.5.1 Market size and forecast
6.6 Pneumococcal disease
6.6.1 Market size and forecast
6.7 Rotavirus
6.7.1 Market size and forecast
6.8 Others
6.8.1 Market size and forecast
Part 7. Global market for vaccine by end user
7.1 Pediatric
7.1.1 Market size and forecast
7.2 Adults
7.2.1 Market size and forecast
Part 8. Global market for vaccine by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast
Part 9. Key competitor profiles
9.1 Abbott Laboratories
9.2 AstraZeneca plc
9.3 Bavarian Nordic A/S
9.4 Emergent BioSolutions Inc.
9.5 GlaxoSmithKline plc
9.6 Johnson & Johnson (J&J)
9.7 Merck & Co., Inc.
9.8 Merck & Co., Inc.
9.9 Pfizer Inc.
9.10 Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
Abbott Laboratories
AstraZeneca plc
Bavarian Nordic A/S
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Johnson & Johnson (J&J)
Merck & Co., Inc.
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2020 |
Forecast Year | 2021-2027 |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.